Giant primary malignant mesothelioma of the liver: A case report

International Journal of Surgery Case Reports 2016 November [Epub ahead of print] [Link] Haji Ali R, Khalife M, El Nounou G, Zuhri Yafi R, Nassar H, Aidibe Z, Raad R, Abou Eid R, Faraj W Abstract INTRODUCTION: Malignant mesothelioma is a rare neoplasm of mesothelial cells arising most frequently in the pleura or peritoneum and…

Read More

Residual fibre lung burden among patients with pleural mesothelioma who have been occupationally exposed to asbestos

Occupational and Environmental Medicine 2016 November 7 [Epub ahead of print] [Link] Merler E, Somigliana A, Girardi P, Barbieri PG Abstract OBJECTIVES: To evaluate the lungs asbestos fibres concentration in participants with malignant pleural mesothelioma (MPM) who have been occupationally exposed. METHODS: The lung samples were obtained from pleuropneumonectomies or autopsies of 271 male MPMs.…

Read More

Biphasic Malignant Pleural Mesothelioma Masquerading as a Primary Skeletal Tumor

Case Reports in Pulmonology [Epub 31 August] [Link] Gleason JB, Tashtoush B, Diacovo MJ Abstract Biphasic malignant pleural mesothelioma is a rare malignant tumor, usually presenting as a pleural-based mass in a patient with history of chronic asbestos exposure. We herein report a case of a 41-year-old man who presented with chest pain and had…

Read More

Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma

Future Oncology (London, England) 2016 September 21 [Epub ahead of print] [Link] Spatola C, Militello C, Tocco A, Salamone V, Raffaele L, Migliore M, Pagana A, Milazzotto R, Chillura I, Pergolizzi S, Privitera G Abstract The use of novel radiotherapy techniques is widely increasing, allowing clinicians to treat diseases that were previously difficult to treat…

Read More

Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study

Lung Cancer (Amsterdam, Netherlands) 2016 September [Epub 2016 July 20] [Link] Wu H, Walker J, Damhuis RA, Brewster DH, Wild SH; Scottish Diabetes Research Network Epidemiology Group Abstract OBJECTIVES: This study aimed to investigate the effect of metformin on survival of people with type 2 diabetes and pleural mesothelioma. MATERIALS AND METHODS: We conducted a…

Read More

Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma

BMC Cancer 2016 August 19 Link] Bickel A, Koneth I, Enzler-Tschudy A, Neuweiler J, Flatz L, Früh M Abstract BACKGROUND: Pembrolizumab is an anti- Programmed Death 1 (PD-1) antibody approved in melanoma, non-small cell lung cancer and investigated in malignant pleural mesothelioma. The most frequent immunotherapy related autoimmune reactions include dermatitis, pneumonitis, colitis, hypophysitis, uveitis,…

Read More